Sagimet Biosciences
(NASDAQ) SGMT
Sagimet Biosciences Financials at a Glance
Market Cap
$148.26M
Revenue (TTM)
$0.00
Net Income (TTM)
$51.04M
EPS (TTM)
$-1.58
P/E Ratio
-2.88
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.04
Volume
143,862.232
Open
$4.60
Price
$5.04
Volume
143,862.232
Open
$4.60
Previous Close
$4.55
Daily Range
$4.60 - $5.09
52-Week Range
$1.73 - $11.41
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$5.04
Volume
143,862.232
Open
$4.60
Previous Close
$4.55
Daily Range
$4.60 - $5.09
52-Week Range
$1.73 - $11.41
SGMT News
SGMT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sagimet Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
David A. Happel, MBA
Website
www.sagimet.comHeadquarters
San Mateo, CA 94402, US
SGMT Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-38%
Return on Capital
-51%
Return on Assets
-44%
Earnings Yield
-34.72%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$148.26M
Shares Outstanding
32.59M
Volume
143.86K
Short Interest
0.00%
Avg. Volume
575.11K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$56.89M
EBITDA
$56.89M
Operating Cash Flow
$45.65M
Capital Expenditure
$0.00
Free Cash Flow
$45.65M
Cash & ST Invst.
$113.12M
Total Debt
$78.00K
Sagimet Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$148.26M
N/A
Market Cap/Employee
$10.59M
N/A
Employees
14
N/A
Net Income
$9.57M
+40.9%
EBITDA
$12.19M
+24.8%
Quarterly Fundamentals
Net Cash
$113.05M
-25.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$78.00K
+0.0%
Return on Assets
-43.82%
N/A
Return on Invested Capital
-51.08%
N/A
Free Cash Flow
$11.83M
-7.3%
Operating Cash Flow
$11.83M
-7.3%